Tokenized Merck: What's the Difference Between MRKON and MRK?
Merck common stock (MRK) and its tokenized counterpart (MRKON) may seem similar, but they offer distinct financial instruments. MRK is the actual equity in Merck & Co., Inc., a global pharmaceutical company with significant businesses across oncology, cardiometabolic, and respiratory medicine.
Merck's financial profile is heavily influenced by KEYTRUDA, which generated $8.366 billion in sales during Q2 2026, approximately half of the company's total sales. MRKON, on the other hand, represents tokenized economic exposure linked to MRK through a blockchain-based infrastructure.
The key differences between MRK and MRKON include legal ownership, shareholder rights, dividends, trading infrastructure, liquidity, custody, and regulation. Tokenization adds an extra layer of complexity, with investors needing to understand the underlying pharmaceutical story before making investment decisions.